Wassim Kassouf Selected Research

Wassim Kassouf Research Topics

Disease

108	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 12/2004
85	Neoplasms (Cancer) 10/2022 - 05/2003
84	Carcinoma (Carcinomatosis) 01/2022 - 06/2006
17	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 05/2003
14	Neoplasm Metastasis (Metastasis) 11/2015 - 02/2004
12	Non-Muscle Invasive Bladder Neoplasms 10/2022 - 12/2009
11	Renal Cell Carcinoma (Grawitz Tumor) 06/2019 - 05/2007
10	Carcinoma in Situ 01/2019 - 06/2006
8	Margins of Excision 01/2019 - 01/2009
4	Hernia (Hernias) 10/2022 - 08/2005
4	Hydronephrosis 01/2021 - 05/2011
4	Disease Progression 08/2018 - 05/2007
4	Lymphatic Metastasis 01/2013 - 02/2004
3	Pathologic Constriction (Stenosis) 10/2022 - 01/2010
3	Adenocarcinoma 01/2020 - 03/2014
3	Carcinogenesis 11/2015 - 04/2009
2	Obesity 01/2022 - 02/2013
2	Hypertension (High Blood Pressure) 01/2022 - 08/2019
2	Ileus 02/2021 - 12/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2020
2	Kidney Neoplasms (Kidney Cancer) 06/2019 - 06/2018
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2012 - 01/2007
2	Extranodal Extension 03/2012 - 10/2006
2	Necrosis 11/2010 - 04/2010
2	Hematuria 04/2009 - 06/2008
2	Transitional Cell Carcinoma 08/2007 - 03/2006
1	Ureteral Obstruction 10/2022
1	Hypertriglyceridemia 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Sarcopenia 01/2022
1	Neuroendocrine Carcinoma 01/2021
1	Convalescence 08/2020
1	Asymptomatic Diseases 03/2020
1	Small Cell Carcinoma 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2019
1	Ureteral Neoplasms (Ureteral Cancer) 09/2017
1	Body Weight (Weight, Body) 11/2014

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 02/2022 - 06/2008
6	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2009
6	Biological ProductsIBA 03/2017 - 09/2008
5	ErbB Receptors (EGF Receptor)IBA 02/2011 - 11/2005
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2006
4	Gemcitabine FDA Link 01/2018 - 10/2006
4	Gefitinib (Iressa)FDA Link 01/2013 - 11/2005
4	Pharmaceutical PreparationsIBA 09/2010 - 08/2006
3	HMGB1 Protein (HMG1)IBA 01/2021 - 03/2016
3	Prostate-Specific Antigen (Semenogelase)IBA 08/2019 - 05/2003
3	Everolimus FDA Link 04/2017 - 12/2009
3	Indicators and Reagents (Reagents)IBA 10/2013 - 04/2010
3	PPAR gammaIBA 01/2013 - 01/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2008 - 02/2004
2	AndrogensIBA 01/2022 - 05/2003
2	Testosterone (Sustanon)FDA Link 01/2022 - 08/2018
2	atezolizumabIBA 12/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2020
2	B7-H1 AntigenIBA 01/2021 - 08/2020
2	Docetaxel (Taxotere)FDA Link 03/2020 - 08/2006
2	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 02/2015
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2018 - 02/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 02/2015
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2014 - 09/2010
2	TOR Serine-Threonine KinasesIBA 09/2013 - 12/2009
2	Tumor Biomarkers (Tumor Markers)IBA 11/2010 - 04/2007
2	nuclear matrix protein 22IBA 12/2009 - 06/2008
2	Tyrosine Kinase InhibitorsIBA 08/2009 - 11/2005
2	LigandsIBA 04/2009 - 05/2005
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	HDL CholesterolIBA 01/2022
1	NivolumabIBA 12/2021
1	5-alpha Reductase InhibitorsIBA 01/2021
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2021
1	TEMPOIBA 10/2020
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2020
1	NectinsIBA 08/2020
1	Interleukin-13IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2018
1	5-aminolevulinic acid hexyl ester FDA Link 06/2017
1	BCG Vaccine FDA Link 12/2016

Therapy/Procedure

103	Cystectomy 10/2022 - 03/2006
56	Therapeutics 10/2022 - 05/2003
40	Nephroureterectomy 08/2020 - 02/2009
29	Drug Therapy (Chemotherapy) 02/2022 - 10/2006
27	Neoadjuvant Therapy 06/2022 - 07/2007
27	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 01/2007
24	Adjuvant Chemotherapy 01/2020 - 01/2008
11	Radiotherapy 02/2022 - 03/2012
9	Nephrectomy 06/2019 - 05/2007
6	Prostatectomy (Retropubic Prostatectomy) 06/2022 - 07/2007
5	Immunotherapy 05/2021 - 12/2004
4	Castration 01/2022 - 07/2013
4	Urinary Diversion (Ileal Conduit) 11/2019 - 01/2010
3	Transurethral Resection of Bladder 01/2022 - 06/2017
2	Preoperative Exercise 06/2022 - 11/2014
2	Aftercare (After-Treatment) 01/2020 - 08/2018
1	Immunomodulation 05/2021
1	Activities of Daily Living (ADL) 01/2021
1	Length of Stay 08/2020
1	Complementary Therapies (Alternative Medicine) 01/2019
1	Continuity of Patient Care 01/2017
1	Combined Modality Therapy 12/2016